The Justice Department’s criminal division is digging into UnitedHealth (UNH) Group’s pharmacy benefit manager Optum Rx as well as how it reimburses its own doctors under an ongoing probe, people familiar with the matter told Bloomberg’s Chris Strohm and John Tozzi. The previously unreported areas of the probe show the scrutiny is broader than was known and goes beyond an inquiry into possible Medicare fraud, said the report, which added that the Justice Department hasn’t accused UnitedHealth or its executives of wrongdoing and the existence of a probe doesn’t mean that charges will be filed. UnitedHealth referred Bloomberg to a July filing in which the company said it was responding to civil and criminal Justice Department probes and has “full confidence in its practices.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth and Intel: Billionaire David Tepper Pulls the Trigger on These 2 Contrarian Stocks
- ACA Rule Pause Offers Relief to UnitedHealth (UNH) and Peers Facing Rising Costs
- Here’s Why UnitedHealth (UNH) and Elevance Health (ELV) Are Exiting Colorado’s ACA Market
- Moderately bullish activity in UnitedHealth with shares up 1.78%
- Gilead Sciences Stock (GILD) Turns Negative As CVS Says No To HIV Prevention Drug
